Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00205790 · ClinicalTrials.gov registry record · NA

GORE-TEX PROPATEN Vascular Graft Study

A NA study of Peripheral Vascular Diseases, sponsored by W.L.Gore & Associates.

Completed
Registry status
NA
Development phase
200
Enrollment target
18
Study locations

NCT00205790 is a NA study of Peripheral Vascular Diseases that has completed, run by W.L.Gore & Associates. The registered enrollment target is 200 participants, below the 486-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (59% lower). The trial reports 18 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00205790, a NA study of Peripheral Vascular Diseases, has completed, sponsored by W.L.Gore & Associates.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
18
Study locations

Study Summary

To demonstrate equivalence in patency performance of GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts in a peripheral bypass application to support a claim of substantial equivalence.

Interventions

  • DEVICE Vascular graft

Study Locations (18)

Florida

  • Memorial Regional Hospital - Hollywood
  • St. Vincent's Hospital - Jacksonville
  • Sacred Heart Hospital - Pensacola

Massachusetts

  • Baystate Medical Center - Springfield
  • Mercy Medical Center - Springfield

Michigan

  • William Beaumont Hospital - Bingham Farms
  • Borgess Hospital - Kalamazoo

District of Columbia

  • Georgetown University Hospital - Washington D.C.

Georgia

  • Medical Center of Central Georgia - Macon

Kentucky

  • Jewish Hospital - Louisville

Maryland

  • Upper Chesapeake Medical Center - Baltimore

Mississippi

  • University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2003-02
Est. Completion 2007-08
Phase NA

Sponsor

W.L.Gore & Associates

53 total trials

What the Registry Record Tells You About NCT00205790

The ClinicalTrials.gov registry entry for NCT00205790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 486-participant average among 19 other Peripheral Vascular Diseases trials with a reported enrollment target (59% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Vascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Vascular graft is the first listed.

NCT00205790 reports 18 study locations spanning 14 distinct geographic areas - top geographies include Florida, Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT00205790 about?

NCT00205790 is a clinical study titled "GORE-TEX PROPATEN Vascular Graft Study". To demonstrate equivalence in patency performance of GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts in a peripheral bypass application to support a claim of substantial equivalence.

What is the current status of trial NCT00205790?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2003-02. Estimated completion is 2007-08.

What conditions does trial NCT00205790 study?

This clinical trial studies the following conditions: Peripheral Vascular Diseases.

What interventions are being tested in trial NCT00205790?

The interventions under investigation include: Vascular graft (DEVICE).

Who is sponsoring clinical trial NCT00205790?

This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00205790 being conducted?

This trial has 18 study locations across District of Columbia, Florida, Georgia, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Vascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.